Literature DB >> 8628552

Standardizing the measurement of intraocular pressure for clinical research. Guidelines from the Eye Care Technology Forum.

M A Kass1.   

Abstract

Mesh：

Year:  1996        PMID： 8628552     DOI： 10.1016/s0161-6420(96)30741-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  27 in total

1.  Clinical comparison of the Keeler Pulsair 3000 with Goldmann applanation tonometry.

Authors:  V A Parker; J Herrtage; N J Sarkies
Journal:  Br J Ophthalmol       Date:  2001-11       Impact factor: 4.638

2.  The change in intraocular pressure after pupillary dilation in eyes with pseudoexfoliation glaucoma, primary open angle glaucoma, and eyes of normal subjects.

Authors:  Eray Atalay; Nevbahar Tamçelik; Ceyhun Arici; Ahmet Özkök; Metin Dastan
Journal:  Int Ophthalmol       Date:  2014-03-31       Impact factor: 2.031

3.  Limbal rebound tonometry: clinical comparisons and applications.

Authors:  Georgios Bontzos; Michail Agiorgiotakis; Zoi Kapsala; Efstathios Detorakis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-06-28       Impact factor: 3.117

4.  Effectiveness of the ICare rebound tonometer in patients with overestimated intraocular pressure due to tight orbit syndrome.

Authors:  You Kyung Lee; Y K Lee; Ji Young Lee; J Y Lee; Jung Il Moon; J I Moon; Myoung Hee Park; M H Park
Journal:  Jpn J Ophthalmol       Date:  2014-08-29       Impact factor: 2.447

5.  The effect of trabeculectomy on intraocular pressure of the untreated fellow eye in the collaborative initial glaucoma treatment study.

Authors:  Nathan M Radcliffe; David C Musch; Leslie M Niziol; Jeffrey M Liebmann; Robert Ritch
Journal:  Ophthalmology       Date:  2010-06-08       Impact factor: 12.079

Review 6.  Tonometers-which one should I use?

Authors:  Kanza Aziz; David S Friedman
Journal:  Eye (Lond)       Date:  2018-02-19       Impact factor: 3.775

7.  A 4-week, dose-ranging study comparing the efficacy, safety and tolerability of latanoprost 75, 100 and 125 μg/mL to latanoprost 50 μg/mL (xalatan) in the treatment of primary open-angle glaucoma and ocular hypertension.

Authors:  David Eveleth; Carla Starita; Charles Tressler
Journal:  BMC Ophthalmol       Date:  2012-05-18       Impact factor: 2.209

8.  Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study.

Authors:  David C Musch; Brenda W Gillespie; Leslie M Niziol; Paul R Lichter; Rohit Varma
Journal:  Ophthalmology       Date:  2011-05-20       Impact factor: 12.079

9.  Factors associated with intraocular pressure before and during 9 years of treatment in the Collaborative Initial Glaucoma Treatment Study.

Authors:  David C Musch; Brenda W Gillespie; Leslie M Niziol; L Frank Cashwell; Paul R Lichter
Journal:  Ophthalmology       Date:  2007-10-26       Impact factor: 12.079

10.  Comparison between dynamic contour tonometry and Goldmann applanation tonometry.

Authors:  Jooeun Lee; Chang Hwan Lee; Jaewan Choi; Sam Young Yoon; Kyung Rim Sung; Seong Bae Park; Michael S Kook
Journal:  Korean J Ophthalmol       Date:  2009-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.